MGM Targets saw a need for development of a versatile, durable and economical target to better facilitate tactical / personal protection training while being mindful of the household budget. The ...
The latest price target for Century Therapeutics (NASDAQ:IPSC) was reported by Leerink Partners on November 17, 2025. The analyst firm set a price target for $2.00 expecting IPSC to rise to within 12 ...
Global Induced Pluripotent Stem Cell (iPSC) Market · GlobeNewswire Inc. Dublin, Nov. 17, 2025 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies ...
Shares of Century Therapeutics, Inc. (IPSC) have gained 9.7% over the past four weeks to close the last trading session at $5, but there could still be a solid upside left in the stock if short-term ...
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
Caldwell, Idaho – 26 January, 2016 –Regarded as the leader in steel target innovation and manufacturing for over 20 years, MGM Targets saw a need for development of a versatile, durable and economical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results